Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Kidney Cancer
2		Additional conditions recognized in this trial
			Carcinoma, Renal Cell
			Kidney Neoplasms
3		More general conditions related to this trial
			Adenocarcinoma
			Carcinoma
			Kidney Diseases
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Urogenital Neoplasms
			Urologic Diseases
			Urologic Neoplasms
4		Interventions listed in this trial
			anti-thymocyte globulin
			cyclophosphamide
			fludarabine phosphate
5		Additional drug interventions recognized in this trial
			Antilymphocyte Serum
			Fludarabine
			Fludarabine monophosphate
6		More general drug interventions related to this trial
			Alkylating Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antineoplastic Agents, Alkylating
			Antirheumatic Agents
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Myeloablative Agonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			National Heart, Lung, and Blood Institute (NHLBI)